San Diego: “Calcinists” See Years of Compensation Prior to Alzheimer’s
If our summary on Aβ oligomers from the recent conference of the Society for Neuroscience delivered an overdose of news on synaptotoxic Aβ, take this story as an antidote...
6345 RESULTS
Sort By:
If our summary on Aβ oligomers from the recent conference of the Society for Neuroscience delivered an overdose of news on synaptotoxic Aβ, take this story as an antidote...
It may be a surprising idea, but it is becoming clearer that complement factors and MHC Class I proteins are regulators...
A major point of confusion in this field has been that different research groups are working with different kinds of Aβ oligomer...
Neurochem announced last week that it would halt development of tramiprosate (Alzhemed)...
Of all other presentations on Aβ oligomers, a talk by Takami Tomiyama created the greatest stir in the audience...
Over the past decade, researchers have shifted away from a literal interpretation of Alois Alzheimer’s groundbreaking discovery...
Could the failure of cell cycle regulation be an underlying cause of neurodegenerative disorders, including Alzheimer disease?...
The first AD vaccine to be tested in humans, Elan’s AN-1792, stalled in phase 2b...
Cell-based therapies have the potential for treating a variety of diseases...
A mini-symposium at this year’s annual meeting of the Society of Neuroscience devoted attention to the role of glia in brain injury and disease...
The earliest signs of Alzheimer disease are bound to be subtle, arising from perturbations in brain function...
To a bird’s eyes, the San Diego convention center for the past 5 days would have looked like a mile-long human beehive...
A new twist on fluorescent tagging for proteins gives researchers a way to track...
The scenario is all too common: a person with dementia can no longer drive safely, yet family members are reluctant to take away the keys...
The Alzforum coverage of the 37th annual conference of the Society for Neuroscience kicks off with a story about...